RxDoctor Payments DataLook up a doctor →

James Kelly, MD

Internal Medicine · Dillon, SCNPI 1730260480

Payments from drug & device makers

$16,519in general payments, 2019–2025

Across 1,107 payments — averaging $14.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novartis$1K
  • Pfizer$993
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$890
  • Amgen$881
  • Boehringer Ingelheim$822
  • plus $10K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)144$1,936
Novartis67$1,017
Pfizer74$993
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC78$890
Amgen(2 entities)64$881
Boehringer Ingelheim55$822
AstraZeneca37$753
Johnson & Johnson58$722
GSK60$715
Merck44$693
Lilly USA, LLC55$595
Forte Bio-pharma LLC22$581
Abbott31$523
Bayer33$497
Sunovion Pharmaceuticals Inc.29$449
Amarin Pharma, Inc.27$449
Ironwood Pharmaceuticals, Inc28$447
Astellas Pharma US Inc17$317
Novo Nordisk14$257
Takeda Pharmaceuticals U.S.A., Inc.17$239
Corcept Therapeutics12$222
Sanofi-aventis U.S. LLC15$218
Irhythm Technologies, Inc.1$191
Dexcom, Inc.6$189
Sumitomo Pharma America, Inc.8$164
Esperion Therapeutics, Inc.10$152
E.r. Squibb & Sons, L.L.C.10$134
Exact Sciences7$115
Daiichi Sankyo Inc.6$108
Vifor Pharma, Inc.7$105
Mylan Specialty L.p.7$97
Eisai Inc.6$88
Collegium Pharmaceutical, Inc.5$84
Otsuka America Pharmaceutical, Inc.3$69
Axsome Therapeutics, Inc.3$55
Nestle Healthcare Nutrition Inc.4$52
Shield Therapeutics Inc3$51
Boston Scientific3$49
Scilex Pharmaceuticals Inc.2$49
Biohaven Pharmaceuticals, Inc.3$47
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$38
Theratechnologies Inc.2$38
Almatica Pharma LLC2$33
Gilead2$30
Phathom Pharmaceuticals, Inc.3$28
Genentech USA, Inc.2$28
Upsher-smith Laboratories LLC2$28
Avion Pharmaceuticals2$27
Edwards Lifesciences2$26
Seqirus USA Inc1$24
Advanced Respiratory, Inc1$23
Kyowa Kirin, Inc.1$23
Ardelyx, Inc.1$22
Sanofi Pasteur Inc.1$21
Acrotech Biopharma Inc.1$19
Lexicon Pharmaceuticals, Inc.1$18
Medicure Pharma Inc.1$17
Alnylam Pharmaceuticals Inc.1$14
The Binding Site Inc.1$14
Ultragenyx Pharmaceutical Inc.1$12

How this compares

$16,519 in reported general payments places this provider in the 95th percentile of 1,498 internal medicine providers in South Carolina.

See all internal medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$145,872
Medicare patients
180
Services billed
3,005

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Dillon

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →